Performance of Repeat BinaxNOW SARS-CoV-2 Antigen Testing in a Community Setting, Wisconsin, November-December 2020

Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America Pub Date : 2021-04-09 DOI:10.1101/2021.04.05.21254834

M. Shah, P. Salvatore, L. Ford, Emiko Kamitani, M. Whaley, Mitchell Kaitlin, D. Currie, Clint N. Morgan, H. Segaloff, Shirley Lecher, Tarah Somers, Miriam E. Van Dyke, J. Bigouette, Augustina Delaney, Juliana DaSilva, M. O’Hegarty, L. Boyle-Estheimer, Fatima Abdirizak, Sandor E. Karpathy, J. Meece, L J Ivanić, K. Goffard, D. Gieryn, Alana Sterkel, A. Bateman, J. Kahrs, K. Langolf, T. Zochert, N. Knight, Christopher H. Hsu, H. Kirking, J. Tate

引用次数: 17

Abstract

Repeating the BinaxNOW antigen test for SARS-CoV-2 by two groups of readers within 30 minutes resulted in high concordance (98.9%) in 2,110 encounters. BinaxNOW test sensitivity was 77.2% (258/334) compared to real-time reverse transcription-polymerase chain reaction. Same day antigen testing did not significantly improve test sensitivity while specificity remained high.

查看原文本刊更多论文

2020年11月至12月威斯康星州社区环境中重复BinaxNOW SARS-CoV-2抗原检测的性能

两组读者在30分钟内重复进行BinaxNOW SARS-CoV-2抗原检测，结果在2110次接触中一致性高(98.9%)。BinaxNOW检测灵敏度为77.2%(258/334)，与实时逆转录-聚合酶链反应相比。当日抗原检测没有显著提高检测灵敏度，但特异性仍然很高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America

自引率

0.00%

发文量

文献相关原料

公司名称	产品信息	采购帮参考价格